RESTORE Act of 2017

Bill: 115-hr-4079
Sponsor: full_name: Rep. Fitzpatrick, Brian K. [R-PA-8]
Introduced: 2017-10-19
Policy area: Crime and Law Enforcement
Subjects: Administrative remedies

Congressional oversight

Crime prevention

Criminal investigation, prosecution, interrogation

Department of Justice

Drug trafficking and controlled substances

Government information and archives

Government studies and investigations

Health care coverage and access

Licensing and registrations

Medical education

Prescription drugs

Retail and wholesale trades
Latest action: action_date: 2017-11-01
text: Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Summaries:
action_date: 2017-10-19
action_desc: Introduced in House
text: <p><b>Restoring Enforcement Standards to Track Opioids Responsively and Effectively Act of 2017 or the RESTORE Act of 2017</b></p> <p>This bill repeals the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. Provisions of the Controlled Substances Act amended by the Act are restored.</p>

tv_txt: I 115th CONGRESS 1st Session H. R. 4079 IN THE HOUSE OF REPRESENTATIVES October 19, 2017 Mr. Fitzpatrick (for himself, Ms. Sinema , Mrs. Comstock , Mr. Keating , Mr. Jenkins of West Virginia , and Ms. Kuster of New Hampshire ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on the Judiciary , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To repeal Public Law 114–145 to ensure that the Drug Enforcement Administration has the authority to carry out needed enforcement actions for drug diversion control investigations and operations to combat the opioid epidemic.

1. Short title This Act may be cited as the Restoring Enforcement Standards to Track Opioids Responsively and Effectively Act of 2017 or the RESTORE Act of 2017 . 2. Restoring DEA’s authority to carry out needed enforcement actions to combat drug diversion and the opioid epidemic Effective as of the enactment of Public Law 114–145 (the Ensuring Patient Access and Effective Drug Enforcement Act of 2016), such Act (including the amendments made by such Act) is repealed, and the provisions of sections 303 and 304 of the Controlled Substances Act ( 21 U.S.C. 823 , 824) that were amended by Public Law 114–145 are hereby restored as if Public Law 114–145 had not been enacted into law.